ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...
WALTHAM, Mass.--(BUSINESS WIRE)-- Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced today that two of the company’s infectious disease therapies, ZEVTERA ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results